Who Owns Neumora Therapeutics Stock?
NASDAQ: NMRAHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 60.13%
- Held by insiders
- 23.08%
- Institutional holders
- 154
- Institutions 60.1%
- Insiders 23.1%
- Public and other 16.8%
Who owns Neumora Therapeutics stock?
Institutional investors own about 60.1% of Neumora Therapeutics's shares, spread across 154 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 23.08% of NMRA.
The largest institutional holders are Siren, L.L.C. (4.52%), Blackrock Inc. (4.15%) and Softbank Group Corporation (3.24%). Together, the top 10 institutions control 24.3% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their NMRA positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of NMRA
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Siren, L.L.C. | 8.50M | 4.52% | 0.0% |
| Blackrock Inc. | 7.79M | 4.15% | +279.3% |
| Softbank Group Corporation | 6.09M | 3.24% | 0.0% |
| Vanguard Capital Management LLC | 4.67M | 2.49% | +20.0% |
| MIC Capital Management UK LLP | 4.46M | 2.37% | 0.0% |
| FMR, LLC | 3.50M | 1.86% | +0.0% |
| Wellcome Trust Ltd (the) As Trustee Of The Wellcome Trust | 3.31M | 1.76% | 0.0% |
| Geode Capital Management, LLC | 2.61M | 1.39% | +139.9% |
| ICONIQ Capital, LLC | 2.56M | 1.36% | 0.0% |
| Two Sigma Investments, LP | 2.24M | 1.19% | +10.2% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of NMRA
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.44M | 1.83% |
| iShares Trust-iShares Russell 2000 ETF | 2.47M | 1.31% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.13M | 0.60% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.12M | 0.59% |
| iShares Trust-iShares Russell 2000 Growth ETF | 878.70K | 0.47% |
| iShares Trust-iShares Biotechnology ETF | 574.29K | 0.31% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 481.33K | 0.26% |
| SCHWAB STRATEGIC TRUST-Schwab U.S. Small-Cap ETF | 415.64K | 0.22% |
| iShares Trust-iShares Micro-Cap ETF | 351.30K | 0.19% |
| SCHWAB CAPITAL TRUST-Schwab Small-Cap Index Fund | 250.07K | 0.13% |
Frequently asked questions
Who is the largest shareholder of Neumora Therapeutics?
Siren, L.L.C. is the largest institutional shareholder of NMRA, owning 4.52% of shares outstanding (8.50M shares) as of its latest 13F filing.
What percentage of Neumora Therapeutics is owned by institutions?
Institutions own about 60.1% of NMRA shares and 78.2% of the public float.
How much of Neumora Therapeutics do insiders own?
Insiders, such as officers and directors, own about 23.08% of NMRA shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.